High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation

Autor: Gilis, L., Morisset, S., Billaud, G., Ducastelle-Leprêtre, S., Labussière-Wallet, H., Nicolini, F.-E., Barraco, F., Detrait, M., Thomas, X., Tedone, N., Sobh, M., Chidiac, C., Ferry, Tristan, Salles, G., Michallet, M., Ader, Florence, group, Lyon BK

Publikováno v: Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2014, 49 (5), pp.664-670. ⟨10.1038/bmt.2013.235⟩
Bone Marrow Transplantation, 2014, 49 (5), pp.664-670. ⟨10.1038/bmt.2013.235⟩

International audience; BK virus (BKV) reactivation has been increasingly associated with the occurrence of late-onset hemorrhagic cystitis (HC) after allogeneic hematopoietic SCT (allo-HSCT) resulting in morbidity and sometimes mortality. We investi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3972580b80e32c33cd2962315ba3e611
https://hal.archives-ouvertes.fr/hal-01911352

Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor.

Autor: Michallet M, Sobh M, Milpied N, Bay JO, Fürst S, Harousseau JL, Mohty M, Nicolini FE, Labussière H, Tedone N, Morisset S, Vigouroux S, Baumgart J, Tabrizi R, Blaise D

Publikováno v: Annals of Hematology; Aug2012, Vol. 91 Issue 8, p1289-1297, 9p

Outcome of High-Risk and Refractory AML/MDS Patients Receiving a Flamsa Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)

Autor: Detrait, M., Chevallier, P., Sobh, M., Guillaume, T., Thomas, X., Morisset, S., Tedone, N., Delaunay, J., Nicolini, F., Ducastelle, S., Chelghoum, Y., Barraco, F., Labussiere, H., Mohty, M., Michallet, M.

Publikováno v: In Biology of Blood and Marrow Transplantation 2012 18(2) Supplement:S335-S336

Faster Registration on International Donor Registries and Shorter Time to Allogeneic Hematopoietic Stem Cell Transplantation After Having Found a Donor Confers Better Outcome in Acute Leukemia Patients

Autor: Michallet, M., Sobh, M., Morisset, S., Thomas, X., Chelghoum, Y., Labussiere, H., Nicolini, F., Ducastelle, S., Barraco, F., Tedone, N., Fatoum, J., Detrait, M., Rey, S., Dubois, V.

Publikováno v: In Biology of Blood and Marrow Transplantation 2011 17(2) Supplement:S312-S313

Phase II Prospective Multicenter Study of Treosulfan Based Reduced intensity Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies From 10/10 HLA Identical Unrelated Donor

Autor: Michallet, M., Sobh, M., Morisset, S., Tedone, N., Bay, J.O., Harousseau, J.-L., Mohty, M., Yakoub-Agha, I., Buzyn, A., Milpied, N., Nicolini, F.E., Labussiere, H., Baumgart, J., Tabrizi, R., Blaise, D.

Publikováno v: In Biology of Blood and Marrow Transplantation 2011 17(2) Supplement:S285-S285